» Articles » PMID: 33154479

Mapping the Genetic Basis of Diabetes Mellitus in the Australian Burmese Cat (Felis Catus)

Overview
Journal Sci Rep
Specialty Science
Date 2020 Nov 6
PMID 33154479
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes mellitus, a common endocrinopathy affecting domestic cats, shares many clinical and pathologic features with type 2 diabetes in humans. In Australia and Europe, diabetes mellitus is almost four times more common among Burmese cats than in other breeds. As a genetically isolated population, the diabetic Australian Burmese cat provides a spontaneous genetic model for studying diabetes mellitus in humans. Studying complex diseases in pedigreed breeds facilitates tighter control of confounding factors including population stratification, allelic frequencies and environmental heterogeneity. We used the feline SNV array and whole genome sequence data to undertake a genome wide-association study and runs of homozygosity analysis, of a case-control cohort of Australian and European Burmese cats. Our results identified diabetes-associated haplotypes across chromosomes A3, B1 and E1 and selective sweeps across the Burmese breed on chromosomes B1, B3, D1 and D4. The locus on chromosome B1, common to both analyses, revealed coding and splice region variants in candidate genes, ANK1, EPHX2 and LOX2, implicated in diabetes mellitus and lipid dysregulation. Mapping this condition in Burmese cats has revealed a polygenic spectrum, implicating loci linked to pancreatic beta cell dysfunction, lipid dysregulation and insulin resistance in the pathogenesis of diabetes mellitus in the Burmese cat.

Citing Articles

Progress in experimental models to investigate the in vivo and in vitro antidiabetic activity of drugs.

Janapati Y, Junapudi S Animal Model Exp Med. 2024; 7(3):297-309.

PMID: 38837635 PMC: 11228097. DOI: 10.1002/ame2.12442.


Going beyond established model systems of Alzheimer's disease: companion animals provide novel insights into the neurobiology of aging.

de Sousa A, Rigby Dames B, Graff E, Mohamedelhassan R, Vassilopoulos T, Charvet C Commun Biol. 2023; 6(1):655.

PMID: 37344566 PMC: 10284893. DOI: 10.1038/s42003-023-05034-3.


Safety and effectiveness of the sodium-glucose cotransporter inhibitor bexagliflozin in cats newly diagnosed with diabetes mellitus.

Hadd M, Bienhoff S, Little S, Geller S, Ogne-Stevenson J, Dupree T J Vet Intern Med. 2023; 37(3):915-924.

PMID: 37148170 PMC: 10229323. DOI: 10.1111/jvim.16730.


Complex Feline Disease Mapping Using a Dense Genotyping Array.

Hernandez I, Hayward J, Brockman J, White M, Mouttham L, Wilcox E Front Vet Sci. 2022; 9:862414.

PMID: 35782544 PMC: 9244801. DOI: 10.3389/fvets.2022.862414.


Comparative Genomics of the Major Histocompatibility Complex (MHC) of Felids.

Plasil M, Futas J, Jelinek A, Burger P, Horin P Front Genet. 2022; 13:829891.

PMID: 35309138 PMC: 8924298. DOI: 10.3389/fgene.2022.829891.


References
1.
Henson M, OBrien T . Feline models of type 2 diabetes mellitus. ILAR J. 2006; 47(3):234-42. DOI: 10.1093/ilar.47.3.234. View

2.
Osto M, Zini E, Reusch C, Lutz T . Diabetes from humans to cats. Gen Comp Endocrinol. 2012; 182:48-53. DOI: 10.1016/j.ygcen.2012.11.019. View

3.
Samaha G, Beatty J, Wade C, Haase B . The Burmese cat as a genetic model of type 2 diabetes in humans. Anim Genet. 2019; 50(4):319-325. DOI: 10.1111/age.12799. View

4.
Slingerland L, Fazilova V, Plantinga E, Kooistra H, Beynen A . Indoor confinement and physical inactivity rather than the proportion of dry food are risk factors in the development of feline type 2 diabetes mellitus. Vet J. 2007; 179(2):247-53. DOI: 10.1016/j.tvjl.2007.08.035. View

5.
Ohlund M, Egenvall A, Fall T, Hansson-Hamlin H, Rocklinsberg H, Holst B . Environmental Risk Factors for Diabetes Mellitus in Cats. J Vet Intern Med. 2016; 31(1):29-35. PMC: 5259626. DOI: 10.1111/jvim.14618. View